Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

This study has suspended participant recruitment.
(Study was not renewed timely with IRB of record.)
Sponsor:
Information provided by (Responsible Party):
New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier:
NCT00250757
First received: November 4, 2005
Last updated: February 18, 2013
Last verified: February 2013
  Purpose

To develop the hypothesis that quantitative NMR spectroscopy of human semen can be used to diagnose prostate cancer.


Condition
Prostate Cancer

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Prospective
Official Title: Prostate Cancer Diagnosis Through NMR Spectroscopy of Semen and Prostatic Secretions

Resource links provided by NLM:


Further study details as provided by New Mexico Cancer Care Alliance:

Biospecimen Retention:   Samples Without DNA

Semen samples or Prostatic secretions (via prostate massage).


Estimated Enrollment: 40
Study Start Date: October 2005
Estimated Study Completion Date: December 2013
Estimated Primary Completion Date: December 2013 (Final data collection date for primary outcome measure)
Detailed Description:

Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

  Eligibility

Genders Eligible for Study:   Male
Accepts Healthy Volunteers:   Yes
Sampling Method:   Non-Probability Sample
Study Population

Males with and without Prostate cancer.

Criteria

Inclusion Criteria:

  • Any willing subject who meets the male gender requirements, who is competent, agrees to participate, and is able to understand the consent form.

Exclusion Criteria:

  • Not sepcified.
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00250757

Locations
United States, New Mexico
University of New Mexico Cancer Center
Albuquerque, New Mexico, United States, 87106
Sponsors and Collaborators
New Mexico Cancer Care Alliance
Investigators
Principal Investigator: Laurel Sillerud, MD University of New Mexico
  More Information

No publications provided

Responsible Party: New Mexico Cancer Care Alliance
ClinicalTrials.gov Identifier: NCT00250757     History of Changes
Other Study ID Numbers: 2904C
Study First Received: November 4, 2005
Last Updated: February 18, 2013
Health Authority: United States: Institutional Review Board

Keywords provided by New Mexico Cancer Care Alliance:
prostate
NMR Spectroscopy

Additional relevant MeSH terms:
Prostatic Neoplasms
Genital Neoplasms, Male
Urogenital Neoplasms
Neoplasms by Site
Neoplasms
Genital Diseases, Male
Prostatic Diseases

ClinicalTrials.gov processed this record on September 14, 2014